Other than PD and Parkinson-plus syndrome, diseases having structural lesions in the basal ganglia such as vascular parkinsonism and Fahr disease show presynaptic dopaminergic loss on DAT imaging and reduced cerebral blood flow in the basal ganglia on perfusion imaging [14, 15]. This evidence concerns the gene SLC6A3 and bilateral striopallidodentate calcinosis.